London: Genetic screening for common diseases……..Fact or fiction?

The UK’s first public debate on genetic screening is being held at The Wellcome Institute, London, Thursday 8th November 6.30pm – 8.30pm. For more information go to www.geneticconference.com

There has been so much in the press this year about the use of genetic screening as a powerful new diagnostic tool for predicting risk in areas such as:

Heart disease, thrombosis, hypertension, metabolism and obesity, osteoporosis, drug metabolism, and cancer predisposition, especially prostate, breast and ovarian cancers.

But is it really what it is cracked up to be? Is there a proven link between some gene polymorphisms and the onset of age related diseases.

Here for the first time an eminent group of doctors and scientists discuss the facts, the scientific evidence, and the potential application in the physician’s surgery.

For two hours on Thursday evening you can have a unique opportunity to hear, not only from leading researchers and clinicians, but also from doctors who have been using this exciting new tool for over two years in the UK.

The excellent speakers: Prof Stephen Bustin (Barts and The London), Prof Mark McCarthy (Oxford), Dr Paul Jenkins (Barts), Dr Lobo (Barts), Dr Brull (The Whittington).

This is the first event of its kind in the UK and a unique opportunity to learn about this powerful new diagnostic tool.

Places will be limited as the lecture hall only holds 150. So please book your place online as soon as you can, to be assured of your place. There will be a small exhibition alongside the meeting, a good opportunity to network and enjoy a glass of wine afterwards.

To register please call + 44 (0)20 8742 3789 so we can register you. For more information to www.geneticconference.com or email a.misplan@geneticconference.com

This event is sponored by the UK’s Genetic Health, Roche and the magazine Body Language.